Comparison of two different steroid treatments with hyperbaric oxygen for idiopathic sudden sensorineural hearing loss

被引:18
|
作者
Sevil, Ergun [1 ]
Bercin, Sami [2 ]
Muderris, Togay [3 ]
Gul, Fatih [3 ]
Kiris, Muzaffer [2 ]
机构
[1] Karaman State Hosp, Dept Otorhinolaryngol Head & Neck Surg, TR-70100 Karaman, Turkey
[2] Yildirim Beyazit Univ, Dept Otorhinolaryngol Head & Neck Surg, Fac Med, Ankara, Turkey
[3] Ataturk Training & Res Hosp, Dept Otorhinolaryngol Head & Neck Surg, Ankara, Turkey
关键词
Idiopathic sudden sensorineural hearing loss; Hyperbaric oxygen; Steroid; INTRATYMPANIC DEXAMETHASONE; SYSTEMIC THERAPY; DOUBLE-BLIND; EFFICACY; FAILURE;
D O I
10.1007/s00405-015-3791-6
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The purpose of the study was to assess the efficacy of the association of intratympanic (IT) steroid and hyperbaric oxygen (HBO) therapy in patients presenting with idiopathic sudden sensorineural hearing loss (ISSNHL), and to compare this protocol with another consisting of intravenous (IV) steroid administration and HBO therapy. A total of 80 patients diagnosed with ISSNHL were included in this prospective trial. Patients were divided into three categories: a mild-to-moderate ISSNHL group with a pure-tone average (PTA) aecurrency sign60 decibels (dB), a severe ISSNHL group with a PTA of 60-80 dB, and a profound ISSNHL group with a PTA aeyen81 dB. The first protocol consisted of 20 sessions of HBO therapy together with IV methylprednisolone 1 mg/kg body weight and a 10 mg taper every 3 days for 10 days. The second protocol consisted of HBO therapy for 20 sessions, together with an IT injection of dexamethasone at a dose of 4 mg/mL, 0.5-0.7 mL once a day for 7 consecutive days, performed 3 h before the HBO therapy. In the mild-to-moderate ISSNHL patients, the mean hearing gain and successful treatment rate was 19 (0-27) dB and 78.9 %, respectively in the IT + HBO treatment group, and 18 (3-44) dB and 70.5 % in the IV + HBO therapy group. In the severe ISSNHL patients, the mean hearing gain and successful treatment rate was 33 (1-54) dB and 81.8 %, respectively in the IT + HBO treatment group and 33.5 (7-57) dB and 58.2 % in the IV + HBO group. In the profound ISSNHL patients, the mean hearing gain and successful treatment rate was 36 (4-69) dB and 40 %, respectively in the IT + HBO therapy group, and 39.5 (0-92) dB and 72.7 % in the IV + HBO treatment group. The results demonstrated that patients with severe hearing loss success rate was superior in the group submitted to IT + HBO treatment, conversely IV + HBO therapy may be benefit for patients with profound hearing loss. Nevertheless, these clinical results were not statistically significant.
引用
收藏
页码:2419 / 2426
页数:8
相关论文
共 50 条
  • [21] Clinical efficacy of hyperbaric oxygen therapy on idiopathic sudden sensorineural hearing loss
    Bagli, Bekir Selim
    [J]. UNDERSEA AND HYPERBARIC MEDICINE, 2020, 47 (01) : 51 - 56
  • [22] Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss?
    Ebru Topuz
    Ozgur Yigit
    Ugur Cinar
    Huseyin Seven
    [J]. European Archives of Oto-Rhino-Laryngology and Head & Neck, 2004, 261 : 393 - 396
  • [23] Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss?
    Topuz, E
    Yigit, O
    Cinar, U
    Seven, H
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2004, 261 (07) : 393 - 396
  • [24] Efficacy of hyperbaric oxygen therapy in sudden unilateral idiopathic sensorineural hearing loss
    Ercan, Erdinc
    Kablan, Zeynep
    Ergozen, Serkan
    Erdogan, Bulent
    [J]. CUKUROVA MEDICAL JOURNAL, 2021, 46 (04): : 1687 - 1693
  • [25] Comparison of Intratympanic Steroid Injection, Hyperbaric Oxygen and Combination Therapy in Refractory Sudden Sensorineural Hearing Loss
    Yang, Chao-Hui
    Wu, Re-Wen
    Hwang, Chung-Feng
    [J]. OTOLOGY & NEUROTOLOGY, 2013, 34 (08) : 1411 - 1416
  • [26] Hyperbaric Oxygen Treatments Attenuate the Neutrophil-to-Lymphocyte Ratio in Patients with Idiopathic Sudden Sensorineural Hearing Loss
    Li, Hang
    Zhao, Daqing
    Diao, Mingfang
    Yang, Chen
    Zhang, Yu
    Lv, Yan
    Zhao, Jinjing
    Pan, Shuyi
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2015, 153 (04) : 606 - 612
  • [27] Comparison of two different intratympanic corticosteroid injection protocols as salvage treatments for idiopathic sudden sensorineural hearing loss
    Andrianakis, Alexandros
    Moser, Ulrich
    Kiss, Peter
    Holzmeister, Clemens
    Andrianakis, Damianos
    Tomazic, Peter Valentin
    Wolf, Axel
    Graupp, Matthias
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (02) : 609 - 618
  • [28] Comparison of two different intratympanic corticosteroid injection protocols as salvage treatments for idiopathic sudden sensorineural hearing loss
    Alexandros Andrianakis
    Ulrich Moser
    Peter Kiss
    Clemens Holzmeister
    Damianos Andrianakis
    Peter Valentin Tomazic
    Axel Wolf
    Matthias Graupp
    [J]. European Archives of Oto-Rhino-Laryngology, 2022, 279 : 609 - 618
  • [29] Comparing treatments for idiopathic sudden sensorineural hearing loss
    Rauch, Steven D.
    Geller, Lisa N.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2012, 1 (01) : 5 - 7
  • [30] The effectiveness of hyperbaric oxygen in patients with idiopathic sudden sensorineural hearing loss: a systematic review
    Eryigit, Burak
    Ziylan, Fuat
    Yaz, Furkan
    Thomeer, Hans G. X. M.
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2018, 275 (12) : 2893 - 2904